OR WAIT null SECS
Bioclinica® announced the launch of Bioclinica Clinical Adjudication, an offering in which medical specialists and researchers, backed by technology, lead independent Clinical Event Committee review. The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas. Bioclinica will bring in professionals who specilize in each particular endpoint area and this adjudication will ultimately help manage the complete process.
Read the full release here.